当前位置： SCI文献检索 > JAMA Neurology期刊下所有文献 > Progress in Intravenous Thrombolytic Therapy for Acute Stroke.

Progress in Intravenous Thrombolytic Therapy for Acute Stroke.

Abstract：

IMPORTANCE:Intravenous recombinant tissue plasminogen activator (alteplase) was approved by the US Food and Drug Administration in 1996 for the treatment of acute ischemic stroke. Nearly 20 years later, it remains the only approved treatment, despite limitations in both efficacy and safety. With a growing capacity for stroke treatment worldwide, physicians need to understand where we have come from and what the future of stroke treatment might be. OBJECTIVE:To present a historical prospective as well as current trends in thrombolytic therapy, focusing on characteristics of drugs that have worked and clinical trials that are moving the field forward. EVIDENCE REVIEW:Sources are published pivotal clinical trials; seminal articles on physiology, pharmacology, and neuroimanging; and listings from clinical trial registries. FINDINGS:The slow progress in thrombolysis for acute stroke has been multifactorial. A focus on extending the time window for alteplase beyond 4.5 hours has encumbered substantial resources in the field for many years, yet these efforts have been largely unsuccessful. New drug development has also been slow. Several drugs have failed in clinical trials and currently only tenecteplase remains to be tested as a potential alternative to alteplase. The parallel pursuit for catheter-based interventional revascularization in acute stroke, which appears to be successful, has shifted emphasis away from pharmacologically based studies. CONCLUSIONS AND RELEVANCE:Although the field of acute thrombolysis has been making progress slowly for many years, advances in neuroimaging and new clinical trials that combine thrombolytics with other pharmacological and interventional techniques are beginning to gain momentum once again. The emergence of new approaches based largely on combination therapy strategies has reset a course to advance thrombolytic treatment for acute stroke and promises to improve outcomes in acute stroke in the near future.

journal_name

JAMA Neurol

journal_title

JAMA neurology

authors

Marshall RS

doi

10.1001/jamaneurol.2015.0835

subject

Has Abstract

pub_date

2015-08-01 00:00:00

pages

928-34

issue

8

eissn

2168-6149

issn

2168-6157

pii

2299317

journal_volume

72

pub_type

杂志文章,评审

相关文献

JAMA Neurology文献大全
  • Outcomes of Intensive Systolic Blood Pressure Reduction in Patients With Intracerebral Hemorrhage and Excessively High Initial Systolic Blood Pressure: Post Hoc Analysis of a Randomized Clinical Trial.

    abstract：Importance:The safety and efficacy of intensive systolic blood pressure reduction in patients with intracerebral hemorrhage who present with systolic blood pressure greater than 220 mm Hg appears to be unknown. Objective:To evaluate the differential outcomes of intensive (goal, 110-139 mm Hg) vs standard (goal, 140-17...

    journal_title：JAMA neurology

    pub_type： 杂志文章

    doi：10.1001/jamaneurol.2020.3075

    authors： Qureshi AI,Huang W,Lobanova I,Barsan WG,Hanley DF,Hsu CY,Lin CL,Silbergleit R,Steiner T,Suarez JI,Toyoda K,Yamamoto H,for ATACH-II trial investigators.

    更新日期：2020-09-08 00:00:00

  • JC polyomavirus granule cell neuronopathy in a patient treated with rituximab.

    abstract：IMPORTANCE:Progressive multifocal leukoencephalopathy results from lytic infection of the glia by the JC polyomavirus (JCV); JCV granule cell neuronopathy is caused by infection with a mutated form of JCV, leading to a shift in viral tropism from the glia to cerebellar granule cells. This shift results in a clinical sy...

    journal_title：JAMA neurology

    pub_type： 杂志文章

    doi：10.1001/jamaneurol.2013.4668

    authors： Dang L,Dang X,Koralnik IJ,Todd PK

    更新日期：2014-04-01 00:00:00

  • Molecular Pathogenic Basis for GABRG2 Mutations Associated With a Spectrum of Epilepsy Syndromes, From Generalized Absence Epilepsy to Dravet Syndrome.

    abstract：OBJECTIVE:In this review article, we focus on the molecular pathogenic basis for genetic generalized epilepsies associated with mutations in the inhibitory γ-aminobutyric acid (GABAA) receptor γ2 subunit gene, GABRG2 (OMIM 137164), an established epilepsy gene. OBSERVATIONS:The γ-aminobutyric acid (GABAA) receptor γ2 ...

    journal_title：JAMA neurology

    pub_type： 杂志文章,评审

    doi：10.1001/jamaneurol.2016.0449

    authors： Kang JQ,Macdonald RL

    更新日期：2016-08-01 00:00:00

  • Blood pressure and progression of brain atrophy: the SMART-MR Study.

    abstract：IMPORTANCE:Studies have shown that both high and low blood pressure (BP) may play a role in the etiology of brain atrophy. High BP in midlife has been associated with more brain atrophy later in life, whereas studies in older populations have shown a relation between low BP and more brain atrophy. Yet, prospective evid...

    journal_title：JAMA neurology

    pub_type： 杂志文章

    doi：10.1001/jamaneurol.2013.217

    authors： Jochemsen HM,Muller M,Visseren FL,Scheltens P,Vincken KL,Mali WP,van der Graaf Y,Geerlings MI,SMART Study Group.

    更新日期：2013-08-01 00:00:00

  • Preventing Cognitive Decline in Black Individuals With Mild Cognitive Impairment: A Randomized Clinical Trial.

    abstract：Importance:Mild cognitive impairment (MCI) is a transition state between normal cognitive aging and dementia that increases the risk for progressive cognitive decline. Preventing cognitive decline is a public health priority. Objective:To determine whether behavioral activation prevents cognitive and functional declin...

    journal_title：JAMA neurology

    pub_type： 杂志文章,随机对照试验

    doi：10.1001/jamaneurol.2018.2513

    authors： Rovner BW,Casten RJ,Hegel MT,Leiby B

    更新日期：2018-12-01 00:00:00

  • Comprehension of an Elevated Amyloid Positron Emission Tomography Biomarker Result by Cognitively Normal Older Adults.

    abstract：Importance:The goal of Alzheimer disease (AD) prevention together with advances in understanding the pathophysiology of AD have led to clinical trials testing drugs in cognitively unimpaired persons who show evidence of AD biomarkers. Data are needed to inform the processes of describing AD biomarkers to cognitively no...

    journal_title：JAMA neurology

    pub_type： 杂志文章,多中心研究

    doi：10.1001/jamaneurol.2017.2954

    authors： Mozersky J,Sankar P,Harkins K,Hachey S,Karlawish J

    更新日期：2018-01-01 00:00:00

  • Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease.

    abstract：IMPORTANCE:Converging evidence suggests that Alzheimer disease (AD) involves insulin signaling impairment. Patients with AD and individuals at risk for AD show reduced glucose metabolism, as indexed by fludeoxyglucose F 18-labeled positron emission tomography (FDG-PET). OBJECTIVES:To determine whether insulin resistan...

    journal_title：JAMA neurology

    pub_type： 杂志文章

    doi：10.1001/jamaneurol.2015.0613

    authors： Willette AA,Bendlin BB,Starks EJ,Birdsill AC,Johnson SC,Christian BT,Okonkwo OC,La Rue A,Hermann BP,Koscik RL,Jonaitis EM,Sager MA,Asthana S

    更新日期：2015-09-01 00:00:00

  • Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression.

    abstract：IMPORTANCE:The extent to which large-caliber axonal degeneration contributes to Alzheimer disease (AD) progression is unknown. Cerebrospinal fluid (CSF) neurofilament light (NFL) concentration is a general marker of damage to large-caliber myelinated axons. OBJECTIVE:To test whether CSF NFL concentration is associated...

    journal_title：JAMA neurology

    pub_type： 杂志文章

    doi：10.1001/jamaneurol.2015.3037

    authors： Zetterberg H,Skillbäck T,Mattsson N,Trojanowski JQ,Portelius E,Shaw LM,Weiner MW,Blennow K,Alzheimer’s Disease Neuroimaging Initiative.

    更新日期：2016-01-01 00:00:00

  • Current Concepts in Diagnosis and Treatment of Functional Neurological Disorders.

    abstract：Importance:Functional neurological disorders (FND) are common sources of disability in medicine. Patients have often been misdiagnosed, correctly diagnosed after lengthy delays, and/or subjected to poorly delivered diagnoses that prevent diagnostic understanding and lead to inappropriate treatments, iatrogenic harm, un...

    journal_title：JAMA neurology

    pub_type： 杂志文章,评审

    doi：10.1001/jamaneurol.2018.1264

    authors： Espay AJ,Aybek S,Carson A,Edwards MJ,Goldstein LH,Hallett M,LaFaver K,LaFrance WC Jr,Lang AE,Nicholson T,Nielsen G,Reuber M,Voon V,Stone J,Morgante F

    更新日期：2018-09-01 00:00:00

  • Assessment of Incidence and Risk Factors of Intracerebral Hemorrhage Among Participants in the Framingham Heart Study Between 1948 and 2016.

    abstract：Importance:Intracerebral hemorrhage (ICH) has the highest mortality of all stroke types and is the most serious complication of anticoagulation. Data regarding trends in ICH incidence and location-specific risk factors on the population level are conflicting. Objective:To assess long-term population-based trends in th...

    journal_title：JAMA neurology

    pub_type： 杂志文章

    doi：10.1001/jamaneurol.2020.1512

    authors： Lioutas VA,Beiser AS,Aparicio HJ,Himali JJ,Selim MH,Romero JR,Seshadri S

    更新日期：2020-06-08 00:00:00

  • Reactions to Multiple Ascending Doses of the Microtubule Stabilizer TPI-287 in Patients With Alzheimer Disease, Progressive Supranuclear Palsy, and Corticobasal Syndrome: A Randomized Clinical Trial.

    abstract：Importance:Basket-design clinical trials that allow investigation of treatment effects on different clinical syndromes that share the same molecular pathophysiology have not previously been attempted in neurodegenerative disease. Objective:To assess the safety, tolerability, and pharmacodynamics of the microtubule sta...

    journal_title：JAMA neurology

    pub_type： 杂志文章,随机对照试验

    doi：10.1001/jamaneurol.2019.3812

    authors： Tsai RM,Miller Z,Koestler M,Rojas JC,Ljubenkov PA,Rosen HJ,Rabinovici GD,Fagan AM,Cobigo Y,Brown JA,Jung JI,Hare E,Geldmacher DS,Natelson-Love M,McKinley EC,Luong PN,Chuu EL,Powers R,Mumford P,Wolf A,Wang P,Sham

    更新日期：2020-02-01 00:00:00

  • Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping.

    abstract：OBJECTIVE:To determine, in patients identified as seropositive for neuronal voltage-gated potassium channel (VGKC) complex autoantibodies, the spectrum of clinical presentations and frequency of leucine-rich glioma-inactivated protein 1 (LGI1) and contactin-associated protein-like 2 (CASPR2) as defined antigenic neuron...

    journal_title：JAMA neurology

    pub_type： 杂志文章

    doi：10.1001/jamaneurol.2013.592

    authors： Klein CJ,Lennon VA,Aston PA,McKeon A,O'Toole O,Quek A,Pittock SJ

    更新日期：2013-02-01 00:00:00

  • Association Between Cardiovascular Disease and Long-term Exposure to Air Pollution With the Risk of Dementia.

    abstract：Importance:Emerging yet contrasting evidence associates air pollution with incident dementia, and the potential role of cardiovascular disease (CVD) in this association is unclear. Objective:To investigate the association between long-term exposure to air pollution and dementia and to assess the role of CVD in that as...

    journal_title：JAMA neurology

    pub_type： 杂志文章

    doi：10.1001/jamaneurol.2019.4914

    authors： Grande G,Ljungman PLS,Eneroth K,Bellander T,Rizzuto D

    更新日期：2020-07-01 00:00:00

  • Clonal expansion of secondary mitochondrial DNA deletions associated with spinocerebellar ataxia type 28.

    abstract：IMPORTANCE:Progressive external ophthalmoplegia (PEO) is a common feature in adults with mitochondrial (mt) DNA maintenance disorders associated with somatic mtDNA deletions in muscle, yet the causal genetic defect in many patients remains undetermined. OBSERVATIONS:Whole-exome sequencing identified a novel, heterozyg...

    journal_title：JAMA neurology

    pub_type： 杂志文章

    doi：10.1001/jamaneurol.2014.1753

    authors： Gorman GS,Pfeffer G,Griffin H,Blakely EL,Kurzawa-Akanbi M,Gabriel J,Sitarz K,Roberts M,Schoser B,Pyle A,Schaefer AM,McFarland R,Turnbull DM,Horvath R,Chinnery PF,Taylor RW

    更新日期：2015-01-01 00:00:00

  • Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis: Dose-Blinded, Randomized Extension of the Phase 2 BOLD Study.

    abstract：IMPORTANCE:This dose-blinded extension of the phase 2 BOLD (BAF312 on MRI Lesion Given Once Daily) Study in relapsing-remitting multiple sclerosis provides evidence on disease activity and safety of a range of siponimod doses for up to 24 months. OBJECTIVE:To assess the safety and efficacy of siponimod for up to 24 mo...

    journal_title：JAMA neurology

    pub_type： 杂志文章,随机对照试验

    doi：10.1001/jamaneurol.2016.1451

    authors： Kappos L,Li DK,Stüve O,Hartung HP,Freedman MS,Hemmer B,Rieckmann P,Montalban X,Ziemssen T,Hunter B,Arnould S,Wallström E,Selmaj K

    更新日期：2016-09-01 00:00:00

  • The growth and impact of Alzheimer disease centers as measured by social network analysis.

    abstract：IMPORTANCE:Alzheimer disease (AD) is a neurodegenerative disorder with no effective therapies. In 1984, the National Institute on Aging created the first 5 AD centers (ADCs) in an effort to coordinate research efforts into the pathology and treatment of the disease. Since that time, the ADC program has expanded to incl...

    journal_title：JAMA neurology

    pub_type： 杂志文章

    doi：10.1001/jamaneurol.2013.6225

    authors： Hughes ME,Peeler J,Hogenesch JB,Trojanowski JQ

    更新日期：2014-04-01 00:00:00

  • Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease.

    abstract：IMPORTANCE:Synaptic loss is an early pathologic substrate of Alzheimer disease (AD). Neurogranin is a postsynaptic neuronal protein that has demonstrated utility as a cerebrospinal fluid (CSF) marker of synaptic loss in AD. OBJECTIVE:To investigate the diagnostic and prognostic utility of CSF neurogranin levels in a l...

    journal_title：JAMA neurology

    pub_type： 杂志文章

    doi：10.1001/jamaneurol.2016.0086

    authors： Tarawneh R,D'Angelo G,Crimmins D,Herries E,Griest T,Fagan AM,Zipfel GJ,Ladenson JH,Morris JC,Holtzman DM

    更新日期：2016-05-01 00:00:00

  • A 2-Step Cerebrospinal Algorithm for the Selection of Frontotemporal Lobar Degeneration Subtypes.

    abstract：Importance:Cerebrospinal fluid (CSF) core Alzheimer disease (AD) biomarkers have shown an excellent capacity for the in vivo detection of AD. Previous studies have shown that CSF levels of phosphorylated tau (p-tau) also correlate with tau pathology in frontotemporal lobar degeneration (FTLD) after accounting for AD co...

    journal_title：JAMA neurology

    pub_type： 杂志文章

    doi：10.1001/jamaneurol.2018.0118

    authors： Lleó A,Irwin DJ,Illán-Gala I,McMillan CT,Wolk DA,Lee EB,Van Deerlin VM,Shaw LM,Trojanowski JQ,Grossman M

    更新日期：2018-06-01 00:00:00

  • Immunologic Effects of Metformin and Pioglitazone Treatment on Metabolic Syndrome and Multiple Sclerosis.

    abstract：IMPORTANCE:Metabolic syndrome (MetS) is thought to influence several autoimmune diseases, including multiple sclerosis (MS). Anti-inflammatory effects of treatments used for MetS, such as metformin hydrochloride and pioglitazone hydrochloride, have been demonstrated, although clinical evidence supporting use of these t...

    journal_title：JAMA neurology

    pub_type： 杂志文章

    doi：10.1001/jamaneurol.2015.4807

    authors： Negrotto L,Farez MF,Correale J

    更新日期：2016-05-01 00:00:00

  • Association of Early-Onset Alzheimer Disease With Elevated Low-Density Lipoprotein Cholesterol Levels and Rare Genetic Coding Variants of APOB.

    abstract：Importance:Early-onset Alzheimer disease (EOAD) is a rare form of Alzheimer disease (AD) with a large genetic basis that is only partially understood. In late-onset AD, elevated circulating cholesterol levels increase AD risk even after adjusting for the apolipoprotein E ε4 (APOE E4) allele, a major genetic factor for ...

    journal_title：JAMA neurology

    pub_type： 杂志文章

    doi：10.1001/jamaneurol.2019.0648

    authors： Wingo TS,Cutler DJ,Wingo AP,Le NA,Rabinovici GD,Miller BL,Lah JJ,Levey AI

    更新日期：2019-07-01 00:00:00

  • Association of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary Mosaicism.

    abstract：IMPORTANCE:Focal cortical dysplasia (FCD), hemimegalencephaly, and megalencephaly constitute a spectrum of malformations of cortical development with shared neuropathologic features. These disorders are associated with significant childhood morbidity and mortality. OBJECTIVE:To identify the underlying molecular cause ...

    journal_title：JAMA neurology

    pub_type： 杂志文章

    doi：10.1001/jamaneurol.2016.0363

    authors： Mirzaa GM,Campbell CD,Solovieff N,Goold C,Jansen LA,Menon S,Timms AE,Conti V,Biag JD,Adams C,Boyle EA,Collins S,Ishak G,Poliachik S,Girisha KM,Yeung KS,Chung BHY,Rahikkala E,Gunter SA,McDaniel SS,Macmurdo CF,Ber

    更新日期：2016-07-01 00:00:00

  • Cognitive resilience to apolipoprotein E ε4: contributing factors in black and white older adults.

    abstract：IMPORTANCE:Apolipoprotein E (APOE) ε4 is an established risk factor for cognitive decline and the development of dementia, but other factors may help to minimize its effects. OBJECTIVE:Using APOE ε4 as an indicator of high risk, we investigated factors associated with cognitive resilience among black and white older a...

    journal_title：JAMA neurology

    pub_type： 杂志文章

    doi：10.1001/jamaneurol.2014.3978

    authors： Kaup AR,Nettiksimmons J,Harris TB,Sink KM,Satterfield S,Metti AL,Ayonayon HN,Yaffe K,Health, Aging, and Body Composition (Health ABC) Study.

    更新日期：2015-03-01 00:00:00

  • Progressive Brain Atrophy in Super-refractory Status Epilepticus.

    abstract：Importance:Prolonged seizures in super-refractory status epilepticus (SRSE) have been shown to cause neuronal death and reorganization, and visual inspection in individual case studies has demonstrated progressive cortical and subcortical atrophy. At present, magnetic resonance imaging (MRI) studies that evaluate brain...

    journal_title：JAMA neurology

    pub_type： 杂志文章

    doi：10.1001/jamaneurol.2016.1572

    authors： Hocker S,Nagarajan E,Rabinstein AA,Hanson D,Britton JW

    更新日期：2016-10-01 00:00:00

  • Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer's Biomarkers in Daily Practice (ABIDE) Project.

    abstract：Importance:Biomarkers do not determine conversion to Alzheimer disease (AD) perfectly, and criteria do not specify how to take patient characteristics into account. Consequently, biomarker use may be challenging for clinicians, especially in patients with mild cognitive impairment (MCI). Objective:To construct biomark...

    journal_title：JAMA neurology

    pub_type： 杂志文章

    doi：10.1001/jamaneurol.2017.2712

    authors： van Maurik IS,Zwan MD,Tijms BM,Bouwman FH,Teunissen CE,Scheltens P,Wattjes MP,Barkhof F,Berkhof J,van der Flier WM,Alzheimer’s Disease Neuroimaging Initiative.

    更新日期：2017-12-01 00:00:00

  • SQSTM1 mutations in French patients with frontotemporal dementia or frontotemporal dementia with amyotrophic lateral sclerosis.

    abstract：IMPORTANCE:Mutations in the SQSTM1 gene, coding for p62, are a cause of Paget disease of bone and amyotrophic lateral sclerosis (ALS). Recently, SQSTM1 mutations were confirmed in ALS, and mutations were also identified in 3 patients with frontotemporal dementia (FTD), suggesting a role for SQSTM1 in FTD. OBJECTIVE:To...

    journal_title：JAMA neurology

    pub_type： 杂志文章

    doi：10.1001/jamaneurol.2013.3849

    authors： Le Ber I,Camuzat A,Guerreiro R,Bouya-Ahmed K,Bras J,Nicolas G,Gabelle A,Didic M,De Septenville A,Millecamps S,Lenglet T,Latouche M,Kabashi E,Campion D,Hannequin D,Hardy J,Brice A,French Clinical and Genetic Research Net

    更新日期：2013-11-01 00:00:00

  • Short-term Psychological Outcomes of Disclosing Amyloid Imaging Results to Research Participants Who Do Not Have Cognitive Impairment.

    abstract：Importance:The goal of preclinical Alzheimer disease (AD) clinical trials is to move diagnosis and treatment to presymptomatic stages, which will require biomarker testing and disclosure. Objective:To assess the short-term psychological outcomes of disclosing amyloid positron emission tomography results to older adult...

    journal_title：JAMA neurology

    pub_type： 杂志文章

    doi：10.1001/jamaneurol.2020.2734

    authors： Grill JD,Raman R,Ernstrom K,Sultzer DL,Burns JM,Donohue MC,Johnson KA,Aisen PS,Sperling RA,Karlawish J,A4 Study Team.

    更新日期：2020-08-10 00:00:00

  • Reliability of classifying multiple sclerosis disease activity using magnetic resonance imaging in a multiple sclerosis clinic.

    abstract：OBJECTIVE:To assess the reliability of new magnetic resonance imaging (MRI) lesion counts by clinicians in a multiple sclerosis specialty clinic. DESIGN:An observational study. SETTING:A multiple sclerosis specialty clinic. PATIENTS:Eighty-five patients with multiple sclerosis participating in a National Institutes ...

    journal_title：JAMA neurology

    pub_type： 杂志文章

    doi：10.1001/2013.jamaneurol.211

    authors： Erbayat Altay E,Fisher E,Jones SE,Hara-Cleaver C,Lee JC,Rudick RA

    更新日期：2013-03-01 00:00:00

  • Woman with x-linked recessive dystonia-parkinsonism: clue to the epidemiology of parkinsonism in Filipino women?

    abstract：IMPORTANCE:Despite recessive inheritance, X-linked dystonia-parkinsonism (Lubag disease) has also been described in women presenting with a late-onset isolated parkinsonian syndrome. Interestingly, unlike in other populations, there is a slight female predominance in the prevalence of parkinsonism in the Philippines. ...

    journal_title：JAMA neurology

    pub_type： 杂志文章

    doi：10.1001/jamaneurol.2014.56

    authors： Domingo A,Lee LV,Brüggemann N,Freimann K,Kaiser FJ,Jamora RD,Rosales RL,Klein C,Westenberger A

    更新日期：2014-09-01 00:00:00

  • Sex and Race Differences in the Association of Incident Ischemic Stroke With Risk Factors.

    abstract：Importance:Race-specific and sex-specific stroke risk varies across the lifespan, yet few reports describe sex differences in stroke risk separately in black individuals and white individuals. Objective:To examine incidence and risk factors for ischemic stroke by sex for black and white individuals. Design, Setting, ...

    journal_title：JAMA neurology

    pub_type： 杂志文章

    doi：10.1001/jamaneurol.2018.3862

    authors： Howard VJ,Madsen TE,Kleindorfer DO,Judd SE,Rhodes JD,Soliman EZ,Kissela BM,Safford MM,Moy CS,McClure LA,Howard G,Cushman M

    更新日期：2019-02-01 00:00:00

  • Ischemic stroke and transient ischemic attack in young adults: risk factors, diagnostic yield, neuroimaging, and thrombolysis.

    abstract：BACKGROUND:Approximately 10% to 14% of ischemic strokes occur in young adults. OBJECTIVE:To investigate the yield of diagnostic tests, neuroimaging findings, and treatment of ischemic strokes in young adults. DESIGN:We retrospectively reviewed data from our Get with the Guidelines-Stroke database from 2005 through 20...

    journal_title：JAMA neurology

    pub_type： 杂志文章

    doi：10.1001/jamaneurol.2013.575

    authors： Ji R,Schwamm LH,Pervez MA,Singhal AB

    更新日期：2013-01-01 00:00:00